Skip to main content

Table 7 Excess hazard ratio (EHR) of death within five years after diagnosis for women compared to men, Estonia, 1995–2006

From: Sex differences in cancer survival in Estonia: a population-based study

Cancer site EHR (95% CI)* EHR adjusted for age (95% CI) EHR adjusted for age and extent (95% CI) EHR adjusted for age, extent and subsite** (95% CI)
Mouth, pharynx 0.54 (0.46–0.63) 0.54 (0.46–0.64) 0.60 (0.51–0.71) 0.66 (0.56–0.78)
Stomach 0.92 (0.86–0.98) 0.88 (0.82–0.94) 0.90 (0.84–0.96) 0.91 (0.85–0.97)
Colon 1.05 (0.96–1.15) 1.01 (0.92–1.11) 1.10 (1.00–1.21) 1.09 (0.99–1.19)
Rectum 0.98 (0.88–1.10) 0.92 (0.83–1.03) 1.00 (0.90–1.11) 0.99 (0.89–1.10)
Pancreas 1.00 (0.91–1.09) 0.94 (0.85–1.03) 0.97 (0.88–1.06)  
Lung 0.90 (0.85–0.96) 0.87 (0.82–0.93) 0.81 (0.76–0.86)  
Skin melanoma 0.53 (0.43–0.66) 0.52 (0.43–0.64) 0.68 (0.55–0.84) 0.72 (0.58–0.90)
Kidney 0.76 (0.67–0.87) 0.72 (0.63–0.83) 0.81 (0.70–0.93)  
Bladder 1.03 (0.86–1.24) 0.92 (0.77–1.11) 0.96 (0.80–1.15)  
  1. *All models include year of follow-up and period of diagnosis.
  2. **Mouth, pharynx: lip (ICD–O–3 C00), oral cavity and tongue (C01-06), salivary glands (C07–08), pharynx and other (C09–14); Stomach: cardia (C16.0), non-cardia (C16.1–16.4), other (C16.5–16.9); Colon: right (C18.0–18.3), transverse (C18.4), left (C18.5–18.7), other (C18.8–18.9); Rectum: rectosigmoid junction (C19), rectum (C20), anus and anal canal (C21); Skin melanoma: head and neck (C44.0–44.4), trunk (C44.5), upper limbs (C44.6), lower limbs (C44.7), other (C44.8–44.9).